COMMUNIQUÉS West-GlobeNewswire

EssilorLuxottica: Disclosure of transactions in own shares

22/04/2025 - 18:00

Disclosure of transactions in own shares Paris, France (April 22, 2025 - 6:00 pm) – In accordance with the authorization granted by the Annual Shareholders’ Meeting on April 30, 2024, EssilorLuxottica declares that from [...]

Press release: Sequana Medical announces the Annual and Extraordinary General Meetings of Shareholders on 22 May 2025

22/04/2025 - 18:00

Sequana Medical announces the Annual and Extraordinary General Meetings of Shareholders on 22 May 2025 Publication of Annual Report 2024 Ghent, Belgium – 22 April 2025 – Sequana Medical NV (Euronext Brussels: SEQUA) ( [...]

Elite Clinical Network and HealthyU Clinics Announce Strategic Partnership to Expand Access to Clinical Research

22/04/2025 - 18:28

MESA, Ariz., April 22, 2025 (GLOBE NEWSWIRE) -- Elite Clinical Network , a leading nationwide integrated clinical research site organization, has announced a strategic partnership with HealthyU Clinics , a digitally [...]

MULTIMEDIA UPDATE: AVAVA™ Receives FDA Clearance for Revolutionary Acne Scar Treatment using Focal Point Technology™

22/04/2025 - 19:50

BOSTON, April 22, 2025 (GLOBE NEWSWIRE) -- AVAVA™, a medical aesthetics innovation company redefining energy-based skin therapy, announced today that its advanced acne scar treatment using Focal Point Technology™ has [...]

Cronos Unveils New Spinach® 1.2g Vapes and SOURZ by Spinach® Gummies Enhanced with Rare Cannabinoids

22/04/2025 - 14:00

TORONTO, April 22, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc.’s (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) best-selling cannabis brand, Spinach®, is thrilled to introduce three all-new 1.2g vape products, [...]

Daxor Corporation to Exhibit at the 45th International Society for Heart and Lung Transplant (ISHLT) Annual Meeting and Scientific Sessions

22/04/2025 - 14:00

Daxor Brings Advanced Blood Volume Analysis Solutions to Elite Heart and Lung Transplantation Forum Oak Ridge, TN, April 22, 2025 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume [...]

Catalyst Pharmaceuticals to Report First Quarter 2025 Financial Results on May 7, 2025

22/04/2025 - 14:03

The Company will Host a Conference Call and Webcast on May 8, 2025, at 8:30 AM ET CORAL GABLES, Fla., April 22, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a [...]

SCIENTURE announces manufacturing and supply chain readiness for ArbliTM, (losartan potassium) Oral Suspension, 10mg/mL for a target product launch in July 2025.

22/04/2025 - 14:05

TAMPA, FL, April 22, 2025 (GLOBE NEWSWIRE) -- SCIENTURE HOLDINGS, INC. NASDAQ: SCNX), a holding company for existing and planned pharmaceutical operating companies focused on providing enhanced value to patients, [...]

Theranica Announces Coverage Policy from the Second Largest U.S. Health Insurer for Its Nerivio® REN Wearable Migraine Treatment, Reaching Access for 80 Million Americans

22/04/2025 - 14:10

The policy expands access to this effective, non-drug treatment for members as young as 8 years old who are diagnosed with migraine BRIDGEWATER, N.J. and NETANYA, Israel, April 22, 2025 (GLOBE NEWSWIRE) -- Theranica , a [...]

BlueGenes Partners with Level Care to Revolutionize Medication Management for Union Members

22/04/2025 - 14:15

SCOTTSDALE, Ariz., April 22, 2025 (GLOBE NEWSWIRE) -- BlueGenes , a pioneering technology company specializing in permission medicine, today announced a strategic partnership with Level Care, the healthcare division of [...]

The Best Natural Testosterone Booster Supplements For Men:~ Honest Customer Reviews 2025

22/04/2025 - 14:17

NEW YORK, April 22, 2025 (GLOBE NEWSWIRE) -- Low testosterone levels can cause many problems in men, such as less muscle, less energy, less libido and low mood. You may want to find a solution, but you don’t know which [...]

Transactions under Novonesis’ share buyback program

22/04/2025 - 14:25

Please read the announcement in PDF Attachment 2025_19_Share_buyback_program

Neuronetics to Report First Quarter 2025 Financial and Operating Results and Host Conference Call

22/04/2025 - 14:30

MALVERN, Pa., April 22, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who [...]

Intelligent Bio Solutions Expands Global Reach with Latin American Spanish Language Integration into Drug Screening System

22/04/2025 - 14:30

Company expands Intelligent Fingerprinting Drug Screening System multilingual capabilities to meet growing demand across Latin American Spanish-speaking markets Latin American drug screening market projected to reach [...]

Enzo Biochem, Inc. Announces Review of Strategic Alternatives after Receiving Multiple Inquiries Regarding a Potential Transaction

22/04/2025 - 14:30

Forms Special Committee of the Board to Lead Evaluation of Viable Options for Maximizing Shareholder Value Engages Independent Financial and Legal Advisors to Support Thorough Process Remains Committed to Maintaining [...]

Rakovina Therapeutics Congratulates Scientific Advisor Dr. Artem Cherkasov on Global Recognition for Breakthrough AI Innovation in Drug Discovery

22/04/2025 - 14:30

VANCOUVER, British Columbia, April 22, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO), a biopharmaceutical company advancing innovative cancer therapies through artificial intelligence (AI)- [...]

Day One to Report First Quarter 2025 Financial Results Tuesday, May 6, 2025

22/04/2025 - 14:30

BRISBANE, Calif., April 22, 2025 (GLOBE NEWSWIRE) -- Day One Biopharmaceuticals (Nasdaq: DAWN) (“Day One” or the “Company”), a biopharmaceutical company dedicated to developing and commercializing targeted therapies for [...]

Ernexa Therapeutics Announces New Data to be Presented at AACR Annual Meeting 2025

22/04/2025 - 14:30

Conference attendees will get first look at new data that supports the potential of ERNA-101 to boost anti-tumor immunity in ovarian cancer CAMBRIDGE, Mass., April 22, 2025 (GLOBE NEWSWIRE) -- Ernexa Therapeutics ( [...]

AP Biosciences Doses First Patient in Phase 1/2 Clinical Trials of AP402 for HER2+ Cancer Patients

22/04/2025 - 14:30

TAIPEI, Taiwan, April 22, 2025 (GLOBE NEWSWIRE) -- AP Biosciences, a clinical-stage biopharmaceutical company dedicated to transforming cancer therapy through development of innovative bispecific antibodies, today [...]